Ligand ID: AY6

Drugbank ID:
Rimonabant
(DB06155)

Indication:
Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite....

LIST OF BINDING INTERFACES for query 'DB06155'
(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details
6AJI_A_AY6A1001	6aji	AY6	Rimonabant (DB06155)	Mycobacterium smegmatis (strain atcc 700084 / mc(2)155); enterobacteria phage t4	DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN,ENDOLYSIN	MMPL Phage_lysozyme	19	VAL A 245 LEU A 248 ILE A 249 GLY A 252 ILE A 253 TYR A 257 PHE A 260 ILE A 297 ILE A 319 VAL A 638 GLY A 641 LEU A 642 ASP A 645 TYR A 646 PHE A 649 LEU A 686 VAL A 689 ALA A 690 LEU A 708	AY6 A1001		Details
DrReposER ID	PDB	Ligand	Drug	Organism	Macromolecule	Pfam	Res.	Interface	HETATM	View	Details

[["6AJI_A_AY6A1001","6aji","AY6","Rimonabant (DB06155)","Mycobacterium smegmatis (strain atcc 700084 \/ mc(2)155);enterobacteria phage t4","DRUG EXPORTERS OF THE RND SUPERFAMILY-LIKE PROTEIN,ENDOLYSIN","MMPL;Phage_lysozyme",19,"VAL A 245;LEU A 248;ILE A 249;GLY A 252;ILE A 253;TYR A 257;PHE A 260;ILE A 297;ILE A 319;VAL A 638;GLY A 641;LEU A 642;ASP A 645;TYR A 646;PHE A 649;LEU A 686;VAL A 689;ALA A 690;LEU A 708","AY6 A1001\r"]]